Standard Biotools (LAB) Current Assets (2010 - 2026)

Standard Biotools (LAB) has 17 years of Current Assets data on file, last reported at $521.5 million in Q1 2026.

• On a quarterly basis, Current Assets rose 51.58% year-over-year to $521.5 million in Q1 2026; TTM through Mar 2026 was $521.5 million, a 51.58% increase from a year earlier, with the FY2025 full-year figure at $454.3 million, up 20.85% from the prior year.
• Current Assets for Q1 2026 stood at $521.5 million, up from $454.3 million in the prior quarter.
• Over the last five years, Current Assets for LAB reached as high as $547.6 million in Q1 2024 and fell as low as $73.2 million in Q1 2022.
• Historically, Current Assets has averaged $330.8 million across 5 years, with a median of $344.0 million in 2025.
• Across the five-year window, Current Assets jumped 220.79% in 2022 and plunged 37.17% in 2025, its largest moves.
• Year by year, Current Assets stood at $208.8 million in 2022, then slipped by 24.23% to $158.2 million in 2023, then jumped by 137.58% to $375.9 million in 2024, then increased by 20.85% to $454.3 million in 2025, then gained by 14.79% to $521.5 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $521.5 million in Q1 2026, $454.3 million in Q4 2025, and $472.4 million in Q3 2025.